Additional information Peer review information Nature Chemical Biology thanks Dohoon Kim and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Veterinary administration
If you are navigating GLP-1 treatment alongside an eating disorder history, an active eating disorder, or simply a complicated relationship with food and your body, you deserve care that sees the full picture
discuss with provider) Belief you should be able to manage without medication (examine this assumption) Dislike of ongoing treatment (understandable, but weigh against alternatives) Whats your realistic expectation
The global SUSTAIN and PIONEER phase III clinical trial programs have studied the effectiveness and safety of once-weekly subcutaneous semaglutide and once-daily oral semaglutide
In the case of semaglutide, some healthcare providers have observed changes in seizure patterns among their patients with epilepsy